cholecystokinin (27-33) has been researched along with gabexate in 1 studies
| Studies (cholecystokinin (27-33)) | Trials (cholecystokinin (27-33)) | Recent Studies (post-2010) (cholecystokinin (27-33)) | Studies (gabexate) | Trials (gabexate) | Recent Studies (post-2010) (gabexate) |
|---|---|---|---|---|---|
| 39 | 0 | 0 | 743 | 53 | 106 |
| Protein | Taxonomy | cholecystokinin (27-33) (IC50) | gabexate (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 0.9 | |
| Coagulation factor X | Homo sapiens (human) | 4.61 | |
| Plasminogen | Homo sapiens (human) | 0.431 | |
| Urokinase-type plasminogen activator | Homo sapiens (human) | 0.431 | |
| Serine protease hepsin | Homo sapiens (human) | 0.383 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baile, CA; McLaughlin, CL; Peikin, SR | 1 |
1 other study(ies) available for cholecystokinin (27-33) and gabexate
| Article | Year |
|---|---|
Decreased pancreatic CCK receptor binding and CCK-stimulated amylase release in Zucker obese rats.
Topics: Amylases; Animals; Body Weight; Carbachol; Culture Techniques; DNA; Dose-Response Relationship, Drug; Esters; Female; Gabexate; Guanidines; Pancreas; Peptide Fragments; Rats; Rats, Zucker; Receptors, Cell Surface; Receptors, Cholecystokinin; Sincalide | 1984 |